Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2009-02-28
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH) will evaluate the technology and its impact of this telemonitoring system on quality of care (i.e. process measures), patient outcomes and direct healthcare costs from an NHS perspective.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supporting Care and Independence at Home
NCT00189852
Home Electronic Monitoring of Chronic Heart Failure
NCT02486887
CHF Home Telemonitoring: A Home Telemonitoring Service for Chronic Heart Failure Patients on Trial
NCT02489370
Effects of Remote Patient Monitoring on Heart Failure Management
NCT00778986
Testing the Effects of Telehealth Monitoring on Rehospitalization and Self Care for Heart Failure Patients in Home Care
NCT00300261
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The ethical issue is how to determine those that will receive home-based monitoring and those that will be denied. The study requires that participants are matched for severity of their condition in each arm and this could deny some from the potential benefits of monitoring. However, as only a limited number of home-based monitors are available and all participants will continue to receive normal health care services, we believe that those denied monitoring will not receive care that is different to patients not in the study and the ethical issues are acceptable.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Group provided with home-based monitor
No interventions assigned to this group
2
Group receives no home-based monitor
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nottingham City Primary Care Trust
UNKNOWN
Brunel University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Malcolm Clarke
Reader
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malcolm Clarke, PhD
Role: PRINCIPAL_INVESTIGATOR
Brunel University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nottingham PCT
Nottingham, Nottinghamshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nottingham-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.